financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
3M's Q2 Adjusted Earnings Increase, Net Sales Decline
3M's Q2 Adjusted Earnings Increase, Net Sales Decline
Jul 26, 2024
06:58 AM EDT, 07/26/2024 (MT Newswires) -- 3M ( MMM ) reported Q2 adjusted earnings Friday of $1.93 per diluted share, up from $1.39 a year earlier. Analysts polled by Capital IQ expected $1.68. Net sales for the quarter ended June 30 were $6.26 billion compared with $6.28 billion a year earlier. Analysts polled by Capital IQ expected $5.83 billion....
Insulet expects to beat revenue estimates on strong insulin pump demand
Insulet expects to beat revenue estimates on strong insulin pump demand
Jul 26, 2024
July 26 (Reuters) - Insulet ( PODD ) reported preliminary second-quarter revenue above Wall Street estimates on Friday, as it benefited from strong demand for its insulin delivery devices. The Massachusetts-based company manufactures and sells insulin delivery devices, under brand Omnipod, which eliminate the need for multiple daily injections using syringes or insulin pens for people with insulin-dependent diabetes. The...
--Select Water Solutions Keeps Dividend at $0.06 per Class A Share, Payable Aug. 16 to Holders as of Aug. 5
--Select Water Solutions Keeps Dividend at $0.06 per Class A Share, Payable Aug. 16 to Holders as of Aug. 5
Jul 26, 2024
05:27 AM EDT, 07/26/2024 (MT Newswires) -- Price: 11.49, Change: +0.26, Percent Change: +2.29 ...
Bristol Myers second-quarter results beat expectations, helped by new drugs
Bristol Myers second-quarter results beat expectations, helped by new drugs
Jul 26, 2024
July 26 (Reuters) - Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis. The company also raised its earnings forecast for the full year. You're really seeing the transformation of our business to the new growth portfolio, Chief...
Copyright 2023-2026 - www.financetom.com All Rights Reserved